» Articles » PMID: 32613902

Time Matters: Early-phase Multiple Sclerosis is Accompanied by Considerable Impairments Across Multiple Domains

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2020 Jul 3
PMID 32613902
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Impairments across multiple domains are a disabling consequence of multiple sclerosis (MS). Originating from preventive medical strategies, the "time matters"-perspective has become a focal point when treating MS. In particular, early detection of physical and cognitive deficits, along with deficits in patient-reported outcomes seems crucial to further optimize both pharmacological and non-pharmacological MS treatment strategies. Therefore, this topical review investigates the level of impairments across multiple domains (physical function, cognitive function, and patient-reported outcomes) in the early stage of MS (⩽5 years since diagnosis, including clinically isolated syndrome (CIS)), when compared to matched healthy controls. Even at early disease stages, studies show impairments corresponding to 8%-34% and small-to-large numerical effect sizes (0.35-2.85) in MS/CIS patients across domains. This evidence call for early screening programs along with early interventions targeting the multiple impaired domains. This further highlights the importance of preventive initiatives preserving and/or restoring physical and cognitive reserve capacity if possible.

Citing Articles

Comparing cognitive impairment using MACFIMS in patients with multiple sclerosis and healthy controls: a systematic review and meta-analysis.

Nasirzadeh A, Mohammadi M, Arab Bafrani M, Mohammadi A, Bakhtiari-Dovvombaygi H BMC Neurol. 2024; 24(1):454.

PMID: 39563246 PMC: 11575216. DOI: 10.1186/s12883-024-03943-2.


Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sample.

De Nadai A, Zamora R, Finch A, Miller D, Ontaneda D, Gunzler D Mult Scler. 2024; 30(13):1642-1652.

PMID: 39420575 PMC: 11568927. DOI: 10.1177/13524585241282763.


CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage.

Ziccardi S, Tamanti A, Ruggieri C, Guandalini M, Marastoni D, Camera V Neurol Neuroimmunol Neuroinflamm. 2024; 11(6):e200301.

PMID: 39178066 PMC: 11368234. DOI: 10.1212/NXI.0000000000200301.


Disrupted hemodynamic response within dorsolateral prefrontal cortex during cognitive tasks among people with multiple sclerosis-related fatigue.

Baldasso B, Raza S, Islam S, Burry I, Newell C, Hillier S PLoS One. 2024; 19(6):e0303211.

PMID: 38837991 PMC: 11152297. DOI: 10.1371/journal.pone.0303211.


Factors affecting driving performance in patients with Multiple Sclerosis - still an open question.

Seddiq Zai S, das Nair R, Heesen C, Buhmann C, Pedersen A, Pottgen J Front Neurol. 2024; 15:1369143.

PMID: 38481946 PMC: 10933050. DOI: 10.3389/fneur.2024.1369143.